US SB2917 | 2013-2014 | 113th Congress
Status
Completed Legislative Action
Spectrum: Bipartisan Bill
Status: Passed on December 16 2014 - 100% progression
Action: 2014-12-16 - Became Public Law No: 113-233.
Text: Latest bill text (Enrolled) [PDF]
Spectrum: Bipartisan Bill
Status: Passed on December 16 2014 - 100% progression
Action: 2014-12-16 - Became Public Law No: 113-233.
Text: Latest bill text (Enrolled) [PDF]
Summary
Adding Ebola to the FDA Priority Review Voucher Program Act - (Sec. 2) Amends the Federal Food, Drug, and Cosmetic Act to add filoviruses, a family of viruses that includes the Ebola virus, to the list of tropical diseases under the priority review voucher program, which awards vouchers to sponsors of human drug applications that are approved to prevent or treat tropical diseases. (A voucher entitles the holder to have a future human drug application acted upon by the Food and Drug Administration (FDA) within six months.) Changes the process by which infectious diseases that do not significantly impact developed nations and disproportionately affect poor and marginalized populations can be designated as tropical diseases from rulemaking to order of the Secretary of Health and Human Services (HHS). Allows priority review vouchers to be transferred between sponsors of human drug applications any number of times. Reduces from 365 days to 90 days the advance notice required before submitting a human drug application subject to a priority review voucher.
Title
Adding Ebola to the FDA Priority Review Voucher Program Act
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2014-12-16 | House | Became Public Law No: 113-233. |
| 2014-12-16 | House | Signed by President. |
| 2014-12-10 | House | Presented to President. |
| 2014-12-03 | House | Motion to reconsider laid on the table Agreed to without objection. |
| 2014-12-03 | House | On passage Passed without objection. (text: CR H8344) |
| 2014-12-03 | House | Considered by unanimous consent. (consideration: CR H8344) |
| 2014-12-03 | House | Mr. Bilirakis asked unanimous consent to take from the Speaker's table and consider. |
| 2014-12-03 | House | Held at the desk. |
| 2014-12-03 | House | Message on Senate action sent to the House. |
| 2014-12-03 | House | Received in the House. |
| 2014-12-02 | Senate | Passed Senate without amendment by Unanimous Consent. (consideration: CR S6271; text as passed Senate: CR S6271) |
| 2014-11-19 | Senate | Placed on Senate Legislative Calendar under General Orders. Calendar No. 602. |
| 2014-11-19 | Senate | Committee on Health, Education, Labor, and Pensions. Reported by Senator Harkin without amendment. Without written report. |
| 2014-11-19 | Senate | Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably. |
| 2014-11-12 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB5729 (Same As) 2014-11-21 - Referred to the Subcommittee on Health.
Subjects
Drug safety, medical device, and laboratory regulation
Drug therapy
Health
Infectious and parasitic diseases
Drug therapy
Health
Infectious and parasitic diseases
